Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer

By Stanford Marianne M   McFadden Grant  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 9, 2007-09 ,pp. : 1415-1425

Informa Healthcare

Access to resources Recommend Favorite

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

By Thorne Steve H   Kirn David H  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1307-1321

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?

By Lawson Keith A.   Morris Don G.  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 891-903

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of Phase I and II trials

By Kirn D.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 3, 2001-05 ,pp. : 525-538

Informa Healthcare

Access to resources Recommend Favorite

Humoral immunotherapy of multiple myeloma: perspectives and perplexities

By Di Bernardo Andrea   Macor Paolo   Guarnotta Carla   Franco Giovanni   Florena Ada Maria   Tedesco Francesco   Tripodo Claudio  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 6, 2010-06 ,pp. : 863-873

Informa Healthcare

Access to resources Recommend Favorite